The key players in this market are QIAGEN (Netherlands), Revvity (US), Beijing Wantai Biopharmaceutical Co., Ltd. (China), Sanofi (France), Endo, Inc. (US), bioMérieux (France), SD Biosensor, INC. (South Korea) The latent TB testing market is projected to grow to USD 773.4 million by 2029 from USD 582.5 million in 2024, at a CAGR of 5.8% […]
